[HTML][HTML] SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort

E Finch, R Lowe, S Fischinger, M de St Aubin… - PLoS …, 2022 - journals.plos.org
… However, existing large studies examining the relative risk of reinfection in antibody
SARS-CoV-2 infection and reinfection over time, we analysed PCR and serological testing data from

[HTML][HTML] SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

LJ Abu-Raddad, H Chemaitelly, P Coyle… - …, 2021 - thelancet.com
… can occur in individuals with detectable antibodies for SARS-CoV-2 infection, even in some
with high antibodyMulti-center nationwide comparison of seven serology assays reveals a …

[HTML][HTML] Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

F Gallais, P Gantner, T Bruel, A Velay, D Planas… - …, 2021 - thelancet.com
… ) who have recovered from COVID-19, we described the dynamics of SARS-CoV-2
humoral … anti-SARS-CoV-2 antibody titers decline, the risk of reinfection within a year post-infection

Anti-SARS-CoV-2 antibodies persist for up to 13 months and reduce risk of reinfection

F Gallais, P Gantner, T Bruel, A Velay, D Planas… - Medrxiv, 2021 - medrxiv.org
SARS-CoV-2 antibody titers do indeed decline, the risk of reinfection within a year post-infection
We also calculated the incidence of SARS-CoV-2 infection/reinfection per month, …

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

CH Hansen, D Michlmayr, SM Gubbels, K Mølbak… - The lancet, 2021 - thelancet.com
SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre
UK that found an 83% lower risk of reinfection for at least 5 months after the first infection. …

[HTML][HTML] Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study

P Kohler, S Güsewell, M Seneghini, T Egger, O Leal… - BMC medicine, 2021 - Springer
… Although our median follow-up of 8 months is among the longest compared with other studies,
our point estimate (RR 0.22) for protection from re-infection with SARS-CoV-2 is perfectly …

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

AT Hanrath, BAI Payne, CJA Duncan - Journal of Infection, 2021 - journalofinfection.com
… of SARS-CoV-2 transmission occurred in our setting from October to November 2020,
approximately 7 monthsSARS-CoV-2 nucleocapsid IgG antibody testing was undertaken on the …

[HTML][HTML] SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort …

VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk… - The Lancet, 2021 - thelancet.com
SARS-CoV-2 infection rates of antibody-positive compared with … SARS-CoV-2 infection
rates of antibody-positive compared with antibody-negative health-care workers in England: a …

Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection

V Hall, S Foulkes, F Insalata, P Kirwan… - … England Journal of …, 2022 - Mass Medical Soc
… The SIREN study is an ongoing, multicenter, prospective … an antibody test result consistent
with previous SARS-CoV-2months after the emergence of SARS-CoV-2 and 10 months

SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks

LJ Abu-Raddad, H Chemaitelly, P Coyle, JA Malek… - MedRxiv, 2021 - medrxiv.org
SARS-CoV-2 PCR testing and using viral genome sequencing, we quantified the risk of
reinfection at ∼2 reinfections … has been expanding in Qatar during the last few months [14, 16, 17…